These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
469 related items for PubMed ID: 19578932
1. Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population. Iwamoto N, Kawakami A, Fujikawa K, Aramaki T, Kawashiri SY, Tamai M, Arima K, Ichinose K, Kamachi M, Yamasaki S, Nakamura H, Nakashima M, Mizokami A, Goto A, Fukuda T, Matsuoka N, Ueki Y, Tsukada T, Migita K, Shoumura F, Kawabe Y, Shibatomi K, Mine M, Ida H, Origuchi T, Aoyagi K, Eguchi K. Mod Rheumatol; 2009; 19(5):488-92. PubMed ID: 19578932 [Abstract] [Full Text] [Related]
3. When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET). Dougados MR, van der Heijde DM, Brault Y, Koenig AS, Logeart IS. J Rheumatol; 2014 Oct; 41(10):1922-34. PubMed ID: 25128520 [Abstract] [Full Text] [Related]
6. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis. Fleischmann R, Koenig AS, Szumski A, Nab HW, Marshall L, Bananis E. Rheumatology (Oxford); 2014 Nov; 53(11):1984-93. PubMed ID: 24907147 [Abstract] [Full Text] [Related]
7. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators. Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331 [Abstract] [Full Text] [Related]
8. The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis. Pope JE, Haraoui B, Thorne JC, Vieira A, Poulin-Costello M, Keystone EC. Ann Rheum Dis; 2014 Dec; 73(12):2144-51. PubMed ID: 23979914 [Abstract] [Full Text] [Related]
10. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA. Keystone E, Freundlich B, Schiff M, Li J, Hooper M. J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659 [Abstract] [Full Text] [Related]
11. Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. van der Heijde D, Klareskog L, Boers M, Landewé R, Codreanu C, Bolosiu HD, Pedersen R, Fatenejad S, TEMPO Investigators. Ann Rheum Dis; 2005 Nov; 64(11):1582-7. PubMed ID: 15860509 [Abstract] [Full Text] [Related]
16. Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis. Keystone EC, Pope JE, Thorne JC, Poulin-Costello M, Phan-Chronis K, Vieira A, Haraoui B, CAMEO Investigators. Rheumatology (Oxford); 2016 Feb; 55(2):327-34. PubMed ID: 26361879 [Abstract] [Full Text] [Related]
20. Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study. Kojima T, Yabe Y, Kaneko A, Takahashi N, Funahashi K, Kato D, Hanabayashi M, Asai S, Hirabara S, Asai N, Hirano Y, Hayashi M, Miyake H, Kojima M, Ishiguro N. Rheumatology (Oxford); 2015 Jan; 54(1):113-20. PubMed ID: 25102861 [Abstract] [Full Text] [Related] Page: [Next] [New Search]